Works matching AU Fluge, Ø

Results: 19

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Published in:

2012

By:

Myklebust MP;
Fluge ø;
Immervoll H;
Skarstein A;
Balteskard L;
Bruland O;
Dahl O;
Myklebust, M P;
Fluge, Ø;
Immervoll, H;
Skarstein, A;
Balteskard, L;
Bruland, O;
Dahl, O

Publication type:

journal article

MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer.

Published in:

2011

By:

Myklebust, M P;
Bruland, O;
Fluge, Ø;
Skarstein, A;
Balteskard, L;
Dahl, O;
Fluge, Ø

Publication type:

journal article

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.

Published in:

2009

By:

Fluge, Ø.;
Gravdal, K.;
Carlsen, E.;
Vonen, B.;
Kjellevold, K.;
Refsum, S.;
Lilleng, R.;
Eide, T. J.;
Halvorsen, T. B.;
Tveit, K. M.;
Otte, A. P.;
Akslen, L. A.;
Dahl, O.;
Fluge, Ø;
Norwegian Gastrointestinal Cancer Group

Publication type:

journal article

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.

Published in:

British Journal of Cancer, 2012, v. 107, n. 10, p. 1684, doi. 10.1038/bjc.2012.463

By:

Myklebust, M P;
Li, Z;
Tran, T H;
Rui, H;
Knudsen, E S;
Elsaleh, H;
Fluge, Ø;
Vonen, B;
Myrvold, H E;
Leh, S;
Tveit, K M;
Pestell, R G;
Dahl, O

Publication type:

Article

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Published in:

British Journal of Cancer, 2012, v. 106, n. 4, p. 756, doi. 10.1038/bjc.2011.548

By:

Myklebust, M P;
Fluge, Ø;
Immervoll, H;
Skarstein, A;
Balteskard, L;
Bruland, O;
Dahl, O

Publication type:

Article

Gene expression reveals two distinct groups of anal carcinomas with clinical implications.

Published in:

2008

By:

Bruland, O;
Fluge, Ø;
Immervoll, H;
Balteskard, L;
Myklebust, M P;
Skarstein, A;
Dahl, O;
Fluge, O;
Myklebust, Mp

Publication type:

journal article

Pseudoprogression in high‐grade glioma.

Published in:

Acta Neurologica Scandinavica, 2013, v. 127, p. 31, doi. 10.1111/ane.12047

By:

Knudsen‐Baas, K. M.;
Moen, G.;
Fluge, Ø.;
Storstein, A.

Publication type:

Article

P14.62 Overall survival from glioblastoma: partial resection versus biopsy.

Published in:

Neuro-Oncology, 2021, v. 23, p. ii49, doi. 10.1093/neuonc/noab180.171

By:

Bjorland, L S;
Fluge, Ø;
Kurz, K D;
Gilje, B;
Mahesparan, R;
Ushakova, A;
Farbu, E

Publication type:

Article

Overall survival and causes of death in elderly patients with Hodgkin lymphoma—a Norwegian population‐based case‐control study.

Published in:

Hematological Oncology, 2023, v. 41, p. 370, doi. 10.1002/hon.3164_267

By:

Lia, K.;
Jørgensen, R. R. K.;
Wold, B. L.;
Fluge, Ø.;
Fagerli, U.;
Bersvendsen, H.;
Bø, I. B.;
Bhargava, S.;
Fosså, A.

Publication type:

Article

BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH‐RISK LARGE B‐CELL LYMPHOMA (NLG‐LBC‐06 PHASE II TRIAL): IMPACT OF CTDNA AND TP53 ABERRATIONS ON CLINICAL OUTCOME.

Published in:

Hematological Oncology, 2023, v. 41, p. 51, doi. 10.1002/hon.3163_21

By:

Leppa, S.;
Meriranta, L.;
Arffman, M.;
Jørgensen, J.;
Karjalainen‐Lindsberg, M.;
Beiske, K.;
Pedersen, M.;
Drott, K.;
Fluge, Ø.;
Jyrkkiö, S.;
Brown, P.;
Holte, H.

Publication type:

Article

BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS OF A NORDIC PHASE 2 STUDY.

Published in:

Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.27_2879

By:

Leppä, S;
Jørgensen, J;
Karjalainen‐Lindsberg, M‐L;
Beiske, K;
Nørgaard, P;
Drott, K;
Pasanen, A;
Karihtala, K;
Mannisto, S;
Wold, B;
Brodtkorb, M;
Fagerli, Unn‐M;
Larsen, T. S;
Munksgaard, L;
Fluge, Ø;
Jyrkkiö, S;
Brown, P. d. N;
Holte, H

Publication type:

Article

YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS.

Published in:

Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.92_2629

By:

Leppä, S.;
Jørgensen, J.;
Tierens, A.;
Meriranta, L.;
Østlie, I.;
Brown, P.;
Fagerli, U.;
Larsen, T.S.;
Mannisto, S.;
Munksgaard, L.;
Maisenhølder, M.;
Vasala, K.;
Meyer, P.;
Jerkeman, M.;
Björkholm, M.;
Fluge, Ø.;
Jyrkkiö, S.;
Ralfkiaer, E.;
Spetalen, S.;
Karjalainen‐Lindsberg, M.

Publication type:

Article

REDUCED SEXUAL FUNCTION IN LONG‐TERM MALE LYMPHOMA SURVIVORS AFTER HIGH DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION.

Published in:

Hematological Oncology, 2019, v. 37, p. 544, doi. 10.1002/hon.231_2631

By:

Bersvendsen, H.S.;
Haugnes, H.S.;
Fagerli, U.;
Fluge, Ø.;
Holte, H.;
Smeland, K.B.;
Kiserud, C.E.

Publication type:

Article

YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS.

Published in:

Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.92_2629

By:

Leppä, S.;
Jørgensen, J.;
Tierens, A.;
Meriranta, L.;
Østlie, I.;
Brown, P.;
Fagerli, U.;
Larsen, T.S.;
Mannisto, S.;
Munksgaard, L.;
Maisenhølder, M.;
Vasala, K.;
Meyer, P.;
Jerkeman, M.;
Björkholm, M.;
Fluge, Ø.;
Jyrkkiö, S.;
Ralfkiaer, E.;
Spetalen, S.;
Karjalainen‐Lindsberg, M.

Publication type:

Article

REDUCED SEXUAL FUNCTION IN LONG‐TERM MALE LYMPHOMA SURVIVORS AFTER HIGH DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION.

Published in:

Hematological Oncology, 2019, v. 37, p. 544, doi. 10.1002/hon.231_2631

By:

Bersvendsen, H.S.;
Haugnes, H.S.;
Fagerli, U.;
Fluge, Ø.;
Holte, H.;
Smeland, K.B.;
Kiserud, C.E.

Publication type:

Article

DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH-RISK DLBCL: A COMPARISON OF NORDIC CRY-04 AND CHIC STUDIES.

Published in:

Hematological Oncology, 2017, v. 35, p. 199, doi. 10.1002/hon.2438_62

By:

Leppä, S.;
Joergensen, J.;
Nully Brown, P.;
Fagerli, U.;
Larsen, T.S.;
Janes, R.;
Mannisto, S.;
Munksgaard, L.;
Maisenhölder, M.;
Vasala, K.;
Meyer, P.;
Jerkeman, M.;
Björkholm, M.;
Fluge, Ø.;
Jyrkkiö, S.;
Pedersen, L.M.;
Eriksson, M.;
Holte, H.

Publication type:

Article

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Published in:

2009

By:

Fluge ø;
Mella O;
Fluge, Øystein;
Mella, Olav

Publication type:

journal article

Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.

Published in:

Acta Oncologica, 2016, v. 55, n. 5, p. 547, doi. 10.3109/0284186X.2015.1125015

By:

Kiserud, C. E.;
Fagerli, U-M.;
Smeland, K. B.;
Fluge, Ø.;
Bersvendsen, H.;
Kvaløy, S.;
Holte, H.;
Dahl, A. A.

Publication type:

Article

Pseudoprogression in high-grade glioma.

Published in:

Acta Neurologica Scandinavica: Supplementum, 2013, v. 127, p. 31, doi. 10.1111/ane.12047

By:

Knudsen-Baas, K. M.;
Moen, G.;
Fluge, Ø.;
Storstein, A.

Publication type:

Article